Avid Bioservices Inc (CDMO)

[pphmtoolong]

CP, I don't know anything about clinical trial enrollment patterns. I'm not sure how one could even research the topic.

I suppose someone who has good relations with Peregrine IR could ask for some guidance on what they expected to see.

The scenario of gradually increasing enrollment is consistent with the fact that we don't have a look-in announcement yet. If the announcement comes later because Bavi patients are doing so well, I would welcome that.

As long as Peregrine confirms the trial is on track, I don't see that we have any reason to be concerned about the timing of the first look-in. An early announcement would be bad, and every day that passes just makes me more optimistic.

GLTA, Paul